내시경 기기 시장 : 내시경 유형, 용도, 기술, 응용 분야, 최종 사용자, 유통 채널별 예측(2026-2032년)

The Endoscopy Devices Market is projected to grow by USD 83.49 billion at a CAGR of 7.41% by 2032.

Endoscopy Devices Market Introduction

The endoscopy devices market is becoming a core pillar of minimally invasive diagnosis and therapy as health systems prioritize earlier detection, shorter hospital stays, and procedure efficiency. Demand is supported by the rising burden of gastrointestinal, respiratory, urologic, and gynecologic diseases, along with global screening programs for colorectal cancer. The World Health Organization reported colorectal cancer among the top three cancers worldwide in 2022, reinforcing the clinical value of colonoscopy and related endoscopic procedures.

Device innovation is expanding beyond visualization to include therapeutic instruments, disposable endoscopes, capsule endoscopy, robotics-assisted platforms, reprocessing systems, and image-management software. For manufacturers, providers, and investors, the strongest opportunities are tied to high-definition imaging, infection-prevention workflows, AI-assisted detection, and scalable models that improve access without compromising clinical quality.

Transformative Shifts in the Endoscopy Landscape

The landscape is shifting from conventional diagnostic endoscopy toward integrated, data-enabled procedural ecosystems. Hospitals and ambulatory surgery centers are adopting high-definition, 4K, narrow-band, fluorescence, and endoscopic ultrasound technologies to improve lesion detection and procedural confidence. At the same time, cost pressures and infection-control requirements are strengthening interest in single-use endoscopes, particularly in bronchoscopy, urology, and high-risk settings.

Another major shift is the movement of appropriate procedures from inpatient departments to outpatient and ambulatory centers. This transition is supported by improved sedation protocols, compact endoscopy towers, enhanced cleaning validation, and reimbursement models that favor efficient care delivery. Competitive advantage increasingly depends on lifecycle value, service uptime, consumable compatibility, and clinical evidence rather than hardware performance alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating a cumulative impact across the endoscopy value chain by improving detection, documentation, workflow automation, and training. In 2021, the U.S. FDA authorized the first AI-assisted colonoscopy system for lesion detection, marking an important regulatory milestone. Peer-reviewed clinical studies have shown that computer-aided detection can improve adenoma detection rates, a key quality indicator associated with colorectal cancer prevention.

The next phase extends AI from real-time polyp detection to characterization, procedure navigation, report generation, quality scoring, and predictive maintenance of equipment. Adoption will depend on validated performance across patient populations, cybersecurity, interoperability with hospital IT systems, and transparent governance of clinical decision support. Vendors that combine AI with strong imaging, cloud connectivity, and regulatory discipline are best positioned to scale.

Key Regional Insights

North America remains a high-value region due to established screening guidelines, advanced hospital infrastructure, strong ambulatory surgery center penetration, and early adoption of AI-enabled endoscopy. Europe benefits from organized colorectal cancer screening, quality-focused clinical societies, and regulatory standardization under the European Union medical device framework, although compliance requirements can lengthen commercialization timelines.

Asia-Pacific is an expanding opportunity base, driven by aging populations, rising gastrointestinal disease detection, and healthcare investment in China, India, Japan, South Korea, Australia, and ASEAN markets. Latin America, led by Brazil and Mexico, is improving access through private hospital networks and urban specialty care, while the Middle East is investing in specialist centers across the GCC. Africa remains underpenetrated, with demand concentrated in urban tertiary facilities and shaped by training, procurement, maintenance, and infrastructure gaps.

Key Group Insights

Within ASEAN, growing private healthcare capacity, medical tourism, and government investment are increasing demand for flexible endoscopy, laparoscopic visualization, and infection-control solutions. The GCC is advancing through hospital modernization, specialist gastroenterology centers, and procurement strategies that favor premium systems with service support. The European Union offers scale through harmonized standards, but suppliers must align with strict clinical evidence, post-market surveillance, and MDR compliance.

BRICS markets combine large patient pools with uneven access, creating opportunities for tiered portfolios, local partnerships, and training-led adoption. G7 countries represent the highest concentration of advanced endoscopy platforms, AI integration, quality reporting, and outpatient procedural pathways. NATO-aligned markets overlap with many high-income health systems where cybersecurity, supply-chain resilience, equipment traceability, and trusted vendor relationships increasingly influence procurement decisions.

Key Country Insights

The United States leads in procedural volume, AI adoption, ambulatory endoscopy, and premium visualization systems, while Canada emphasizes publicly funded access and guideline-driven screening. Mexico and Brazil are expanding through private hospital groups and urban specialty centers. In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain mature demand supported by cancer screening, established gastroenterology networks, and quality standards, whereas Russia presents a more complex procurement environment shaped by localization requirements and sanctions-related supply constraints.

China is scaling rapidly through hospital investment and domestic device manufacturing, while India combines high disease burden with demand for affordable and durable systems. Japan and South Korea remain innovation-oriented markets with strong imaging expertise, aging populations, and high clinical expectations. Australia benefits from organized screening and high clinical standards, making it a receptive market for advanced endoscopy platforms and evidence-backed AI tools.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves detection, reduces procedure time, and strengthens infection prevention. Product roadmaps should integrate high-definition imaging, AI-assisted detection, ergonomic scope design, and seamless connectivity with electronic health records and image archives. Single-use strategies should be targeted to specialties and settings where infection risk, reprocessing capacity, or turnaround time materially affect outcomes.

Commercial execution should focus on regional portfolio segmentation, training programs, service reliability, and health-economic evidence. Companies can strengthen competitiveness by partnering with hospitals, ambulatory centers, and academic societies to generate real-world data. Leaders should also prepare for stricter post-market surveillance, cybersecurity expectations, and sustainability scrutiny related to disposable devices, reprocessing chemicals, packaging, and circularity requirements.

Research Methodology

This executive summary is developed through secondary research using public health databases, regulatory information, clinical guidelines, peer-reviewed literature, company disclosures, and hospital procurement trends. Sources considered include global cancer statistics, national screening recommendations, medical device regulatory updates, infection-prevention guidance, and evidence from clinical studies on endoscopic imaging and AI-assisted detection.

The analysis applies triangulation across disease burden, procedure migration, technology adoption, reimbursement environment, regulatory requirements, and regional infrastructure. Market interpretation emphasizes verified directional evidence rather than unsupported projections. Insights are structured to support strategic planning for device manufacturers, healthcare providers, distributors, investors, and digital health partners active in endoscopy devices.

Conclusion

Endoscopy devices are moving from standalone visualization tools to intelligent procedural platforms that combine imaging, therapy, software, and service models. The market is supported by aging demographics, cancer screening, minimally invasive care, outpatient procedure growth, infection-control priorities, and expanding access in emerging health systems.

Future leadership will depend on evidence-based differentiation, AI readiness, infection-control excellence, regulatory discipline, and regional execution. Organizations that deliver measurable clinical value, simplify workflows, and adapt to varied procurement environments will be best positioned to capture growth in the evolving global endoscopy devices market.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Endoscopy Devices Market, by Endoscope Type

• 7.1. Flexible Endoscopes
  • 7.1.1. Colonoscopes
  • 7.1.2. Bronchoscopes
  • 7.1.3. Duodenoscopes
• 7.2. Rigid Endoscopes
  • 7.2.1. Laparoscopes
  • 7.2.2. Arthroscopes
  • 7.2.3. Hysteroscopes
• 7.3. Capsule Endoscopes

8. Endoscopy Devices Market, by Usage Type

• 8.1. Reusable Endoscopes
• 8.2. Single Use Endoscopes

9. Endoscopy Devices Market, by Technology

• 9.1. Fiber Optic Endoscopy
• 9.2. Video Endoscopy
• 9.3. Robot Assisted Endoscopy
• 9.4. 3D Endoscopy

10. Endoscopy Devices Market, by Application

• 10.1. Arthroscopy
  • 10.1.1. Hip Arthroscopy
  • 10.1.2. Knee Arthroscopy
  • 10.1.3. Shoulder Arthroscopy
• 10.2. Gastrointestinal Endoscopy
  • 10.2.1. Colonoscopy
  • 10.2.2. Endoscopic Ultrasound
  • 10.2.3. ERCP
  • 10.2.4. Gastroscopy
• 10.3. Laparoscopy
  • 10.3.1. General Laparoscopy
  • 10.3.2. Gynecological Laparoscopy
  • 10.3.3. Pediatric Laparoscopy
• 10.4. Urological Endoscopy
  • 10.4.1. Cystolithotripsy
  • 10.4.2. Cystoscopy
  • 10.4.3. Ureteroscopy

11. Endoscopy Devices Market, by End User

• 11.1. Ambulatory Surgery Centers
• 11.2. Hospitals
  • 11.2.1. Public
  • 11.2.2. Private
• 11.3. Specialty Clinics

12. Endoscopy Devices Market, by Distribution Channel

• 12.1. Offline
• 12.2. Online

13. Endoscopy Devices Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Endoscopy Devices Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Endoscopy Devices Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Ambu A/S
• 17.2. Aohua Endoscopy Co., Ltd.
• 17.3. Arthrex, Inc.
• 17.4. B. Braun Melsungen AG
• 17.5. Boston Scientific Corporation
• 17.6. CapsoVision, Inc.
• 17.7. CONMED Corporation
• 17.8. Cook Group Incorporated
• 17.9. Dornier MedTech GmbH
• 17.10. Fujifilm Holdings Corporation
• 17.11. Hologic, Inc.
• 17.12. Hoya Corporation
• 17.13. Johnson & Johnson
• 17.14. Karl Storz SE & Co. KG
• 17.15. Medtronic plc
• 17.16. Micro-Tech Endoscopy USA, Inc.
• 17.17. Olympus Corporation
• 17.18. Pristine Surgical LLC
• 17.19. Richard Wolf GmbH
• 17.20. Scivita Medical Technology Co., Ltd.
• 17.21. Shanghai Ankon Medical Technology Co., Ltd.
• 17.22. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 17.23. Smith & Nephew plc
• 17.24. SonoScape Medical Corp.
• 17.25. STERIS plc
• 17.26. Stryker Corporation
• 17.27. Teleflex Incorporated
• 17.28. Wuhan Vathin Medical Instrument Co., Ltd.
• 17.29. XION GmbH